Intravenous levetiracetam: A new treatment alternative for refractory status epilepticus

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 6, 2009, Pages 689-692

  Moddel G ^a   Bunten, S ^b   Dobis, C ^c   Kovac, S ^a   Dogan, M ^a   Fischera, M ^a   Dziewas, R ^a   Schabitz W R ^a   Evers, S ^a   Happe, S ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c St Marien Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; ETIRACETAM; MIDAZOLAM; PHENYTOIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PIRACETAM;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BRAIN DAMAGE; CLINICAL ARTICLE; COMA; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; STUPOR; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIRACETAM; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 66149129578     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.145458     Document Type: Article

References (22)

1. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-1454 (Pubitemid 13158575)
2. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-798
3. Limdi NA, Shimpi AV, Faught E, et al. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005;64:353-355
4. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure 2005;14:164-169 (Pubitemid 40425264)
5. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000;85:77-85. (Pubitemid 30069478)
6. Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004;43:707-724 (Pubitemid 39159001)
7. Benedetti MS. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 2000;14:301-319 (Pubitemid 30690748)
8. Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia 2001;42(Suppl 4):24-27 (Pubitemid 32802083)
9. Patel NC, Landan IR, Levin J, et al. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137-141
10. Mehta S, Wu BY. Case series: Treatment with levetiracetam in nonconvulsive status epilepticus. Epilepsia 2005;46(Suppl 8):220.
11. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54:34-38 (Pubitemid 41328732)
12. Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8:651-654
13. Ramael S, De Smedt F, Toublanc N, et al. Levetiracetam intravenous infusion: safety, tolerability and bioavailability versus oral tablet. Clin Ther 2006;28:733-744
14. Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: A randomised, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47:1128-1135 (Pubitemid 44086747)
15. Baulac M, Voss G, Krygier C, Falter U, LEV NO1166 Study Group. Safety profile of levetiracetam intravenous infusion (1000-3000 mg/day in BID administration) in patients with partial-onset seizures. Epilepsia 2005;46(Suppl 8):169(abstract 2.234).
16. Baulac M, Brodie MJ, Elger CE, et al. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia 2007;48:589-592 (Pubitemid 46365188)
17. Schulze-Bonhage A, Hefft S, Oehl B. Termination of complex partial status epilepticus by intravenous levetiracetam: a case report. J Neurol Neurosurg Psychiatry Mar 12 2007 (Epub ahead of print).
18. Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79:588-589 (Pubitemid 351571881)
19. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60. (Pubitemid 20046592)
20. Jaitly R, Sgro JA, Towne AR, et al. Prognostic value of EEG monitoring after status epilepticus: a prospective adult study. J Clin Neurophysiol 1997;14:326-334 (Pubitemid 28247094)
21. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-976 (Pubitemid 28152839)
22. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205-210 (Pubitemid 34240935)